| Q31858092 | A structurally biased combinatorial approach for discovering new anti-picornaviral compounds |
| Q24550640 | Activity of pleconaril against enteroviruses |
| Q40463235 | Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice. |
| Q28377116 | Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives |
| Q91823296 | Antifungal Triazole Posaconazole Targets an Early Stage of the Parechovirus A3 Life Cycle |
| Q39642808 | Antipoliovirus activity and mechanism of action of 3-methylthio-5-phenyl-4-isothiazolecarbonitrile |
| Q48222908 | Cellular receptor interactions of C-cluster human group A coxsackieviruses |
| Q72152029 | Citrinin hydrate and radicinin: human rhinovirus 3C-protease inhibitors discovered in a target-directed microbial screen |
| Q36928256 | Clinical and diagnostic findings of an echovirus meningitis outbreak in the north west of England |
| Q34073205 | Crystallographic and cryo EM analysis of virion-receptor interactions |
| Q34749241 | Diagnosis and Management of Enteroviral Infections of the Central Nervous System |
| Q28178690 | Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials |
| Q59135002 | Elucidating the Interaction of CF Airway Epithelial Cells and Rhinovirus: Using the Host-Pathogen Relationship to Identify Future Therapeutic Strategies |
| Q30449635 | In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding inhibitors with potent antipicornavirus activity |
| Q30448335 | In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease |
| Q28343611 | In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease |
| Q34375688 | Inhibitors of virus replication: recent developments and prospects |
| Q52545697 | Kinetics of thermal denaturation of human rhinoviruses in the presence of anti-viral capsid binders analyzed by capillary electrophoresis. |
| Q39866449 | Method for detection of picornavirus capsid binders with soluble intercellular adhesion molecule 1. |
| Q35947703 | Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition |
| Q46117915 | Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis |
| Q33841475 | Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export |
| Q37658853 | Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors |
| Q40398238 | Picornavirus inhibitors |
| Q31936167 | Pleconaril: a novel antipicornaviral drug |
| Q36944919 | Potential use of antiviral agents in polio eradication |
| Q35941645 | Prospects for the therapy and prevention of dengue virus infections |
| Q39468942 | Protease inhibitors as antiviral agents. |
| Q40534823 | Protein-Protein Interfaces in Viral Capsids Are Structurally Unique |
| Q39868803 | Rhinovirus-mediated endosomal release of transfection complexes |
| Q33699999 | Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food |
| Q33976480 | Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Pediatric Pharmacology Research Unit Network |
| Q33220088 | Sporadic amyotrophic lateral sclerosis: a hypothesis of persistent (non-lytic) enteroviral infection |
| Q36058227 | Structure of a human rhinovirus complexed with its receptor molecule |
| Q45414083 | Structure of the virus capsid protein VP1 of enterovirus 71 predicted by some homology modeling and molecular docking studies |
| Q45999596 | Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors. |
| Q40749083 | Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics |
| Q44053411 | Synthesis of new 3-methylthio-5-aryl-4-isothiazolecarbonitriles with broad antiviral spectrum |
| Q30448025 | Treatment of the common cold |
| Q34452529 | Virus population dynamics, fitness variations and the control of viral disease: an update |
| Q35366667 | Virus receptors: implications for pathogenesis and the design of antiviral agents. |
| Q74256174 | [Neonatal enterovirus myocarditis] |